Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof

a technology of streptococcus pneumoniae and conjugates, which is applied in the field of multivalent immunogenic compositions, can solve the problems of limited serotype coverage of prevnar® in certain regions of the world, infants and young children's poor response to unconjugated pneumococcal polysaccharides, etc., and achieve enhanced immunogenicity and superior stability

Inactive Publication Date: 2021-06-17
MERCK SHARP & DOHME CORP
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent text describes a method of creating polysaccharide protein conjugates using an aprotic solvent, such as dimethylsulfoxide (DMSO). The use of DMSO during the process results in more stable and immunogenic conjugates for certain serotypes as compared to those made in water. This patent suggests that using DMSO or similar solvents may improve the quality and effectiveness of polysaccharide protein conjugate vaccines.

Problems solved by technology

However, infants and young children respond poorly to unconjugated pneumococcal polysaccharides.
However, there are limitations in serotype coverage with Prevnar® in certain regions of the world and some evidence of certain emerging serotypes in the United States (for example, 19A and others).

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
  • Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
  • Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of S. Pneumoniae Capsular Polysaccharides

[0484]Methods of culturing pneumococci are well known in the art. See, e.g., Chase, 1967, Methods of Immunology and Immunochemistry 1:52. Methods of preparing pneumococcal capsular polysaccharides are also well known in the art. See, e.g., European Patent No. EP 0 497 524 B 1. The process described below generally follows the method described in European Patent No. EP 0 497 524 B1 and is generally applicable to all pneumococcal serotypes.

[0485]Isolates of pneumococcal strains for serotypes 6C, 23B, and 31 were obtained from Centers for Disease Control and Prevention (Atlanta, Ga.). Strains for serotypes 3, 8, 10A, 11A, 12F, 15B, 22F, and 33F were obtained from the University of Pennsylvania (Dr. Robert Austrian). Strains for serotypes 17F and 19A were obtained from the FDA Office of Biologics (Dr. John Robbins). Serotype 7F was obtained from the State University of New York, Downstate Medical Center (Dr. Gerald Schiffman). Isolate...

example 2

Purification of Pneumococcal Polysaccharides

[0488]The purification process for the pneumococcal polysaccharides consisted of several centrifugation, depth filtration, concentration / diafiltration operations, and precipitation steps. All procedures were performed at room temperature unless otherwise specified.

[0489]Inactivated broth from the fermentor cultures of S. pneumoniae were flocculated with a cationic polymer (such as BPA-1000, TRETOLITE® (Baker Hughes Inc., Houston, Tex.), Spectrum 8160, poly(ethyleneimine), and Millipore pDADMAC). The cationic polymers binded to the impurity proteins, nucleic acids and cell debris. Following the flocculation step and an aging period, flocculated solids were removed via centrifugation and multiple depth filtration steps. Clarified broth was concentrated and diafiltered using a 100 kDa to 500 kDa MWCO (molecular weight cutoff) filter. Diafiltration was accomplished using Tris, MgCl2 buffer and sodium phosphate buffer. Diafiltration removed res...

example 3

Structure Identity Analysis of Certain Pneumococcal Serotypes by NMR Testing

[0491]Samples for NMR analysis were prepared by dissolving polysaccharide powder at 5 mg powder / mL solution in deuterium oxide (D2O) containing 0.01% dimethyl sulfoxide (DMSO) and 0.01% 2,2-Dimethyl-2-silapentane-5-sulfonate-d6 sodium salt (DSS-d6). DMSO is an internal standard that was used for quantitative analysis and DSS-d6 was used to set the chemical shift scale to 0 ppm. A one-dimensional proton NMR data set was acquired at 50° C. and a portion of spectrum containing the anomeric resonances as then selectively written as x, y coordinates to an ASCII file for analysis using a Microsoft Excel workbook. The Y coordinates (i.e., spectral profile) were then compared to spectral profiles of capsular bacterial polysaccharides in a reference database. The reference profiles were generated in a similar manner on selected preparations of each serotype thereafter designated as the reference lot. A pairwise compa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
Mwaaaaaaaaaa
Mnaaaaaaaaaa
Login to View More

Abstract

The invention is related to multivalent immunogenic compositions comprising more than one S. pneumoniae polysaccharide protein conjugates, wherein each of the conjugates comprises a polysaccharide from an S. pneumoniae serotype conjugated to a carrier protein, wherein the serotypes of S. pneumoniae are as defined herein. In some embodiments, at least one of the polysaccharide protein conjugates is formed by a conjugation reaction comprising an aprotic solvent. In further embodiments, each of the polysaccharide protein conjugates is formed by a conjugation reaction comprising an aprotic solvent. Also provided are methods for inducing a protective immune response in a human patient comprising administering the multivalent immunogenic compositions of the invention to the patient. The multivalent immunogenic compositions are useful for providing protection against S. pneumoniae infection and diseases caused by S. pneumoniae. The compositions of the invention are also useful as part of treatment regimens that provide complementary protection for patients that have been vaccinated with a multivalent vaccine indicated for the prevention of pneumococcal disease.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]Not ApplicableFIELD OF INVENTION[0002]The present invention provides multivalent immunogenic compositions having distinct polysaccharide-protein conjugates. Each conjugate consists of a capsular polysaccharide prepared from a different serotype of Streptococcus pneumoniae conjugated to a carrier protein, preferably CRM197. The immunogenic compositions provide broad coverage against pneumococcal disease.BACKGROUND OF THE INVENTION[0003]Streptococcus pneumoniae is a Gram-positive bacterium and the most common cause of invasive bacterial disease (such as pneumonia, bacteraemia, meningitis and Otitis media) in infants and young children. Pneumococcus is encapsulated with a chemically linked polysaccharide which confers serotype specificity. There are over 90 known serotypes of pneumococci, and the capsule is the principle virulence determinant for pneumococci, as the capsule not only protects the inner surface of the bacteria from complement,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K39/116A61K47/02A61K47/22A61K47/10A61K39/09A61K9/00A61P31/04
CPCA61K39/116A61K47/02A61K47/22A61K2039/6037A61K39/092A61K9/0019A61P31/04A61K47/10A61K39/385A61K39/39A61K47/64A61K2039/54A61K2039/545A61K2039/55A61K2039/55516A61K2039/70A61K39/145A61K2039/55505
Inventor SMITH, WILLIAM J.MCHUGH, PATRICKWINTERS, MICHAEL ALBERTSKINNER, JULIE M.HE, JIANMUSEY, LUWYABEYGUNAWARDANA, CHITRANANDACUI, YADONG ADAMKOSINSKI, MICHAEL J.
Owner MERCK SHARP & DOHME CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com